BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9045357)

  • 1. [Identification of a variant D(IVa) with anti-D in serum].
    Serra A; Alcorta I; Pereira A; Ordinas A
    Sangre (Barc); 1996 Apr; 41(2):151-3. PubMed ID: 9045357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and serologic characterization of DWI, a novel "high-grade" partial D.
    Körmöczi GF; Legler TJ; Daniels GL; Green CA; Struckmann R; Jungbauer C; Moser S; Flexer M; Schönitzer D; Panzer S; Gassner C
    Transfusion; 2004 Apr; 44(4):575-80. PubMed ID: 15043574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Qualitative and quantitative study of a DVI variant with anti-D in the serum].
    Puig N; Carbonell F; Arriaga F; Lorenzo I; Montoro JA; Soler A; Pérez-Castellanos T; Miravalls C; Marty ML
    Sangre (Barc); 1986; 31(3):335-9. PubMed ID: 3092375
    [No Abstract]   [Full Text] [Related]  

  • 6. Human monoclonal antibodies for the differentiation of RhD categories.
    Ernst M; Weber-Muscan MT; Lenhard V; Sonneborn HH
    Beitr Infusionsther; 1992; 30():388-90. PubMed ID: 1284742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-G antibodies from the RH system. I. Diagnostic antibodies and their clinical significance].
    Kuśnierz-Alejska G
    Acta Haematol Pol; 1989; 20(2):223-8. PubMed ID: 2517857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers.
    Bichler J; Spycher MO; Amstutz HP; Andresen I; Gaede K; Miescher S
    Transfus Med; 2004 Apr; 14(2):165-71. PubMed ID: 15113381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhD variant caused by an in-frame triplet duplication in the RHD gene.
    Pereira JC; Rodrigues MJ; Tilley L; Poole J; Chabert T; Ribeiro ML
    Transfusion; 2011 Mar; 51(3):570-3. PubMed ID: 20738827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric quantification of antigen D sites on red blood cells of partial D and weak D variants in India.
    Kulkarni S; Mohanty D; Gupte S; Vasantha K; Joshi S
    Transfus Med; 2006 Aug; 16(4):285-9. PubMed ID: 16879157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis and current status of the prevention of feto-maternal isoimmunization by anti-D].
    Martín Vega C
    Sangre (Barc); 1997 Jun; 42(3):239-41. PubMed ID: 9381270
    [No Abstract]   [Full Text] [Related]  

  • 16. Variants of RhD--current testing and clinical consequences.
    Daniels G
    Br J Haematol; 2013 May; 161(4):461-70. PubMed ID: 23432139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.
    Kumpel BM
    Vox Sang; 2007 Aug; 93(2):99-111. PubMed ID: 17683353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of an anti-D monoclonal antibody using unconventional techniques].
    Almará A; Biondi C; García Rosasco M; Racca A; Morisoli L; Valverde J
    Sangre (Barc); 1993 Feb; 38(1):69. PubMed ID: 8385809
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
    Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
    Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.